MET and non-small cell lung carcinoma: Moreover, FOXM1 can bind directly to the promoter of MET, which establishes, together with AKT, a positive feedback loop relevant not only to NSCLC (Wang et al,2016) but also to carcinomas of tongue (Yang et al,2018) and pancreas (Cui et al,2016).